Skip to content

Clinical trials

Urinary Bladder, Overactive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Country / region: Canada Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20076
20086
20094
20104
20112
20124
20133
20144
20153
20165
20171
20181
20192
20202
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated7
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan8
Astellas Pharma Inc6
Pfizer5
Astellas Pharma Europe B.V.4
Astellas Pharma Global Development, Inc.3
Astellas Pharma Europe Ltd.2
Barrie Urology Associates2
Duramed Research2
MedtronicNeuro2
Urovant Sciences GmbH2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive55
Urinary Incontinence14
Urinary Incontinence, Urge9
Urologic Diseases5
Lower Urinary Tract Symptoms4
Nocturia4
Prostatic Hyperplasia3
Urinary Bladder Diseases3
Fecal Incontinence2
Cognitive Dysfunction1

Trials

Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.